Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk A/S (UK) (GB:0QIU)
:0QIU
Holding GB:0QIU?
Track your performance easily
0QIU Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr527.60 - kr1,032.20
Previous CloseN/A
Volume862.13K
Average Volume (3M)538.22K
Market Cap
kr2.67T
Enterprise Valuekr3.49T
Total Cash (Recent Filing)$20.70B
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.2
Beta0.60
Next Earnings
Feb 05, 2025EPS Estimate
6.05Last Dividend Ex-Date
Aug 15, 2024Dividend Yield1.65%
Share Statistics
EPS (TTM)21.25
Shares Outstanding3,390,128,000
10 Day Avg. Volume479,313
30 Day Avg. Volume538,221
Standard Deviation0.07
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.08
Price to Cash Flow (P/CF)3.60
P/FCF Ratio4.20
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue16.40
Enterprise Value/Gross Profit17.77
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr814.20Price Target Upside35.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Novo Nordisk News
Options Prices
Currently, No data available
---
Ownership Overview
5.27% Insiders
13.68% Mutual Funds
<0.01% Other Institutional Investors
73.36% Public Companies and
Individual Investors
0QIU FAQ
What was Novo Nordisk A/S (UK)’s price range in the past 12 months?
Novo Nordisk A/S (UK) lowest share price was kr527.60 and its highest was kr1032.20 in the past 12 months.
What is Novo Nordisk A/S (UK)’s market cap?
Novo Nordisk A/S (UK)’s market cap is kr2.67T.
When is Novo Nordisk A/S (UK)’s upcoming earnings report date?
Novo Nordisk A/S (UK)’s upcoming earnings report date is Feb 05, 2025 which is in 18 days.
How were Novo Nordisk A/S (UK)’s earnings last quarter?
Novo Nordisk A/S (UK) released its earnings results on Nov 06, 2024. The company reported kr6.12 earnings per share for the quarter, beating the consensus estimate of kr5.998 by kr0.122.
Is Novo Nordisk A/S (UK) overvalued?
According to Wall Street analysts Novo Nordisk A/S (UK)’s price is currently Undervalued.
Does Novo Nordisk A/S (UK) pay dividends?
Novo Nordisk A/S (UK) pays a Annually dividend of kr9.9 which represents an annual dividend yield of 1.65%. See more information on Novo Nordisk A/S (UK) dividends here
What is Novo Nordisk A/S (UK)’s EPS estimate?
Novo Nordisk A/S (UK)’s EPS estimate is 6.05.
How many shares outstanding does Novo Nordisk A/S (UK) have?
Novo Nordisk A/S (UK) has 3,390,128,000 shares outstanding.
What happened to Novo Nordisk A/S (UK)’s price movement after its last earnings report?
Novo Nordisk A/S (UK) reported an EPS of kr6.12 in its last earnings report, beating expectations of kr5.998. Following the earnings report the stock price went up 8.16%.
Which hedge fund is a major shareholder of Novo Nordisk A/S (UK)?
Currently, no hedge funds are holding shares in GB:0QIU
---
Company Description
Novo Nordisk A/S (UK)
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
---
0QIU Stock 12 Month Forecast
Average Price Target
kr814.20
▲(35.74% Upside)
Technical Analysis
Best Analysts Covering 0QIU
1 Year
1 Year Success Rate
41/53 ratings generated profit
1 Year Average Return
+26.26%
reiterated a buy rating 2 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 77.36% of your transactions generating a profit, with an average return of +26.26% per trade.
---